NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT00295646,"Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid",https://clinicaltrials.gov/study/NCT00295646,,COMPLETED,"The primary objective is, first, the comparison of tamoxifen and anastrozole and, second, the comparison of zoledronate added to standard adjuvant therapy with controls according to disease-free survival (DFS) in premenopausal patients with non-metastatic breast cancer treated with tamoxifen or anastrozole. To assess whether zoledronate added to standard adjuvant therapy can decrease or even prevent bone loss in patients treated with hormonal blockade combined with an antiestrogen or aromatase inhibitor.",YES,Breast Cancer,DRUG: tamoxifen|DRUG: anastrozole|DRUG: zoledronic acid|OTHER: goserelin,"Comparison of Anastrozole vs Tamoxifen in Premenopausal Patients With Non-metastatic Breast Cancer With Respect to Disease-free Survival (DFS), DFS is defined as time from randomization to first occurrence of a local, regional, or distant recurrence, second primary carcinoma (including contralateral breast cancer), or death from any cause, Time from randomization to the analysis data cut-off date when 124 DFS events had occurred. On the analysis data cut-off date, maximum time on study per patient was 102 months.|Comparison of Zoledronate vs no Zoledronate in Premenopausal Patients With Non-metastatic Breast Cancer With Respect to Disease-free Survival (DFS), DFS is defined as time from randomization to first occurrence of a local, regional, or distant recurrence, second primary carcinoma (including contralateral breast cancer), or death from any cause, Time from randomization to the analysis data cut-off date when 124 DFS events had occurred. On the analysis data cut-off date, maximum time on study per patient was 102 months.","Comparison of Anastrozole vs Tamoxifen in Premenopausal Patients With Non-metastatic Breast Cancer With Respect to Recurrence-free Survival (RFS), RFS is defined as time from randomization to first occurrence of a local, regional, or distant recurrence, second primary carcinoma (including contralateral breast cancer), or death from breast cancer, Time from randomization to the analysis data cut-off date when 124 DFS events had occurred. On the analysis data cut-off date, maximum time on study per patient was 102 months.|Comparison of Zoledronate vs no Zoledronate in Premenopausal Patients With Non-metastatic Breast Cancer With Respect to Recurrence-free Survival (RFS), RFS is defined as time from randomization to first occurrence of a local, regional, or distant recurrence, second primary carcinoma (including contralateral breast cancer), or death from breast cancer, Time from randomization to the analysis data cut-off date when 124 DFS events had occurred. On the analysis data cut-off date, maximum time on study per patient was 102 months.|Comparison of Anastrozole vs Tamoxifen in Premenopausal Patients With Non-metastatic Breast Cancer With Respect to Overall Survival (OS), OS is defined as time from randomization to death from any cause, Time from randomization to the analysis data cut-off date when 124 DFS events had occurred. On the analysis data cut-off date, maximum time on study per patient was 102 months.|Comparison of Zoledronate vs no Zoledronate in Premenopausal Patients With Non-metastatic Breast Cancer With Respect to Overall Survival (OS), OS is defined as time from randomization to death from any cause, Time from randomization to the analysis data cut-off date when 124 DFS events had occurred. On the analysis data cut-off date, maximum time on study per patient was 102 months.",,Austrian Breast & Colorectal Cancer Study Group,AstraZeneca|Novartis Pharmaceuticals,FEMALE,ADULT,PHASE3,1803,NETWORK,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,ABCSG-12|CZOL 446 1B 01|Zol-A-01,1999-06,2008-03-27,2018-06-26,2006-02-24,2024-03-15,2024-03-15,"Hospital of Guessing, Guessing, Burgenland, 7540, Austria|Hospital Oberpullendorf, Oberpullendorf, Burgenland, 7350, Austria|Hospital Oberwart, Oberwart, Burgenland, 7400, Austria|State Hospital Klagenfurt, Surgery, Klagenfurt, Carinthia, 9026, Austria|State Hospital Klagenfurt, Klagenfurt, Carinthia, 9026, Austria|Hospital BHB St. Veit, St. Veit a. d. Glan, Carinthia, 9300, Austria|Ordination Dr. Wette, St. Veit a. d. Glan, Carinthia, 9300, Austria|State Hospital Villach, Villach, Carinthia, 9500, Austria|Privat Hospital Villach, Villach, Carinthia, 9504, Austria|State Hospital Wolfsberg, Wolfsberg, Carinthia, 9400, Austria|Hospital Hainburg, Hainburg An Der Donau, Lower Austria, 2410, Austria|Hospital Klosterneuburg, Internal Medicine, Klosterneuburg, Lower Austria, 3400, Austria|Hospital Krems, Krems, Lower Austria, 3500, Austria|Hospital Melk, Melk, Lower Austria, 3390, Austria|Hospital Mistelbach, Mistelbach, Lower Austria, 2130, Austria|Hospital Mödling, Mödling, Lower Austria, 2340, Austria|Hospital Neunkirchen, Neunkirchen, Lower Austria, 2620, Austria|Hospital Scheibbs, Scheibbs, Lower Austria, 3270, Austria|Hospital St. Poelten, St. Poelten, Lower Austria, 3100, Austria|Hospital Tulln, Tulln, Lower Austria, 3430, Austria|Hospital Waidhofen/Thaya, Waidhofen An Der Thaya, Lower Austria, 3830, Austria|Hospital of Wiener Neustadt, Wiener Neustadt, Lower Austria, 2700, Austria|Kardinal Schwarzenberg'sches Hospital, Schwarzach, Salzburg, 5620, Austria|State Hospital Feldbach, Feldbach, Styria, 8330, Austria|Gynaegological Medical University of Graz, Graz, Styria, 8036, Austria|Medical University of Graz, Oncology, Graz, Styria, 8036, Austria|State Hospital Leoben, Leoben, Styria, 8700, Austria|State Hospital Rottenmann, Rottenmann, Styria, 8786, Austria|Brustgesundheitszentrum-Süd Institut / Dr. Thiel, Weiz, Styria, 8160, Austria|District Hospital Hall in Tirol, Hall in Tirol, Tyrol, 6060, Austria|Gynaegological Medical University Innsbruck, Innsbruck, Tyrol, 6020, Austria|District Hospital Kufstein, Kufstein, Tyrol, 6330, Austria|District Hospital Lienz, Lienz, Tyrol, 9900, Austria|Hospital St. Vinzenz, Zams, Tyrol, 6511, Austria|State Hospital Bad Ischl, Bad Ischl, Upper Austria, 4820, Austria|State Hospital Freistadt, Freistadt, Upper Austria, 4240, Austria|State Hospital Gmunden, Gmunden, Upper Austria, 4810, Austria|State Hospital Kirchdorf, Kirchdorf, Upper Austria, 4560, Austria|Hospital BHS Linz, Linz, Upper Austria, 4010, Austria|Hospital Elisabethinen Linz, Linz, Upper Austria, 4010, Austria|General Hospital Linz, Linz, Upper Austria, 4020, Austria|Hospital BHB Linz, Linz, Upper Austria, 4020, Austria|Ordination Dr. Pöstlberger, Linz, Upper Austria, 4020, Austria|Hospital BHS Ried, Ried, Upper Austria, 4910, Austria|State Hospital Rohrbach, Rohrbach, Upper Austria, 4150, Austria|State Hospital Schärding, Schärding, Upper Austria, 4780, Austria|State Hospital Steyr, Steyr, Upper Austria, 4400, Austria|State Hospital Voecklabruck, Internal Medicine, Voecklabruck, Upper Austria, 4840, Austria|State Hospital Voecklabruck, Surgery Dept., Voecklabruck, Upper Austria, 4840, Austria|Klinikum Wels-Grieskirchen, Wels, Upper Austria, 4600, Austria|State Hospital Bregenz, Bregenz, Vorarlberg, 6900, Austria|State Hospital of Dornbirn, Dornbirn, Vorarlberg, 6850, Austria|State Hospital Feldkirch, Feldkirch, Vorarlberg, 6807, Austria|Paracelsus Medical University Salzburg - Oncology, Salzburg, 5020, Austria|Hospital BHB Vienna, Surgery, Vienna, 1020, Austria|Hospital Sanatorium Hera, Vienna, 1090, Austria|Medical University of Vienna, General Hospital, Gynaecology and Obstetrics, Vienna, 1090, Austria|Medical University of Vienna, General Hospital, Vienna, 1090, Austria|Medical University Vienna, General Hospital, Vienna, 1090, Austria|State Hospital Vienna-Hietzing, Vienna, 1130, Austria|Hanusch Hospital, Vienna, 1140, Austria|Wilheminenspital, Internal Medicin I, Vienna, 1160, Austria|Practice Dr. Marschner, Freiburg, Baden-Wuerttemberg, 79106, Germany|Medical Care Center, Ulm, Baden-Wuerttemberg, 89073, Germany|Klinikum St. Marien, Amberg, Bavaria, 92224, Germany|Frauenklinik vom Roten Kreuz, Muenchen, Bavaria, 80637, Germany|Med. University of Munich, Munich, Bavaria, 80337, Germany|Elisabeth-Hospital, Kassel, Hesse, 34117, Germany|Internal-haematological Practice Oldenburg, Oldenburg, Lower Saxony, 26121, Germany|General Hospital Gifhorn, Gifhorn, Saxony, 38518, Germany|Medical University Kiel, Kiel, Schleswig-Holstein, 24105, Germany|Vivantes-Klinikum Friedrichshain, Berlin, 10967, Germany",
